A proteomic approach of pediatric astrocytomas: MiRNAs and network insight

Journal of Proteomics

Volumn 94, Issue , 2013, Pages 162-175

  Ruiz Esparza Garrido, Ruth ^a,d   Velázquez Flores, Miguel Á ^a   Diegopérez Ramírez, Jaime ^a   López Aguilar, Enrique ^a   Siordia Reyes, Georgina ^a   Hernández Ortiz, Magdalena ^b   Martínez Batallar, Ángel G ^b   Encarnación Guevara, Sergio ^b   Salamanca Gómez, Fabio ^c   Arenas Aranda, Diego Julio ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b INSTITUTO DE CIENCIAS FÍSICAS   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Hub proteins; Novel miRNAs; Pediatric astrocytoma; Protein protein interactions; Proteomic

Indexed keywords

CALRETICULIN; MICRORNA; VIMENTIN;

ARTICLE; ASTROCYTOMA; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS;

HUB PROTEINS; NOVEL MIRNAS; PEDIATRIC ASTROCYTOMA; PROTEIN-PROTEIN INTERACTIONS; PROTEOMIC;

ADULT; ASTROCYTOMA; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; PROTEOME; PROTEOMICS; RNA, NEOPLASM;

EID: 84885355048     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.09.009     Document Type: Article

References (57)

1. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007, 114:97-109.
2. Broniscer A., Gajjar A. Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. Oncologist 2004, 9:197-206.
3. Peris-Bonet R., Martínez-García C., Lacour B., Petrovich S., Giner-Ripoll B., Navajas A., et al. Childhood central nervous system tumours-incidence and survival in Europe (1978-1997): report from Automated Childhood Cancer Information System project. Eur J Cancer 2006, 42:2064-2080.
4. Ricard D., Idbaih A., Ducray F., Lahutte M., Hoang-Xuan K., Delattre J.Y. Primary brain tumours in adults. Lancet 2012, 379:1984-1996.
5. Qaddoumi I., Sultan I., Broniscer A. Pediatric low-grade gliomas and the need for new options for therapy: why and how?. Cancer Biol Ther 2009, 8:4-10.
6. Huse J.T., Phillips H.S., Brennan C.W. Molecular subclassification of diffuse gliomas: seeing order in the chaos. Glia 2011, 59:1190-1199.
7. Hambardzumyan D., Squatrito M., Carbajal E., Holland E.C. Glioma formation, cancer stem cells, and akt signaling. Stem Cell Rev 2008, 4:203-210.
8. Jones C., Perryman L., Hargrave D. Pediatric and adult malignant glioma: close relatives or distant cousins?. Nat Rev Clin Oncol 2012, 9:400-413.
9. Deighton R.F., McGregor R., Kemp J., McCulloch J., Whittle I.R. Glioma pathophysiology: insights emerging from proteomics. Brain Pathol 2010, 20:691-703.
10. Brennan C., Momota H., Hambardzumyan D., Ozawa T., Tandon A., Pedraza A., et al. Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS One 2009, 4:e7752.
11. Anagnostopoulos A.K., Dimas K.S., Papathanassiou C., Braoudaki M., Anastasiadou E., Vougas K., et al. Proteomics studies of childhood pilocytic astrocytoma. J Proteome Res 2011, 10:2555-2565.
12. Rutnam Z.J., Yang B.B. The involvement of microRNAs in malignant transformation. Histol Histopathol 2012, 27:1263-1270.
13. Dubuc A.M., Mack S., Unterberger A., Northcott P.A., Taylor M.D. The epigenetics of brain tumors. Methods Mol Biol 2012, 863:139-153.
14. Birks D.K., Barton V.N., Donson A.M., Handler M.H., Vibhakar R., Foreman N.K. Survey of microRNA expression in pediatric brain tumors. Pediatr Blood Cancer 2011, 56:211-216.
15. Costa F.F., Bischof J.M., Vanin E.F., Lulla R.R., Wang M., Sredni S.T., et al. Identification of microRNAs as potential prognostic markers in ependymoma. PLoS One 2011, 6:e25114.
16. Wang X., Zhang H., Zhang A., Han L., Wang K., Liu R., et al. Upregulation of miR-20a and miR-106b is involved in the acquisition of malignancy of pediatric brainstem gliomas. Oncol Rep 2012, 28:1293-1300.
17. Bezginov A., Clark G.W., Charlebois R.L., Dar V.U., Tillier E.R. Coevolution reveals a network of human proteins originating with multicellularity. Mol Biol Evol 2012, 3:332-346.
18. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
19. Encarnación S., Hernández M., Martínez-Batallar G., Contreras S., Vargas Mdel C., Mora J. Comparative proteomics using 2-D gel electrophoresis and mass spectrometry as tools to dissect stimulons and regulons in bacteria with sequenced or partially sequenced genomes. Biol Proced Online 2005, 7:117-135.
20. Perkins D.N., Pappin D.J., Creasy D.M., Cottrell J.S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20:3551-3567.
21. The Uniprot Consortium The universal protein resource (UniProt). Nucleic Acids Res 2008, 36:D190-D195.
22. Schaefer M.H., Fontaine J.F., Vinayagam A., Porras P., Wanker E.E., Andrade-Navarro M.A. HIPPIE: integrating protein interaction networks with experiment based quality scores. PLoS One 2012, 7:e31826.
23. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003, 13:2498-2504.
24. Velázquez-Flores M.Á., Salceda R. Glycine receptor internalization by protein kinases activation. Synapse 2011, 65:1231-1238.
25. Vlachos I.S. DIANA miRPath v. 2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res 2012, 40:W498-W504.
26. Yamasaki T., Seki N., Yamada Y., Yoshino H., Hidaka H., Chiyomaru T., et al. Tumor suppressive microRNA 138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma. Int J Oncol 2012, 41:805-817.
27. Van Steendam K., Tilleman K., De Ceuleneer M., De Keyser F., Elewaut D., Deforce D. Citrullinated vimentin as an important antigen in immune complexes from synovial an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins. Arthritis Res Ther 2010, 12:R132.
28. Jang B., Jeon Y.C., Choi J.K., Park M., Kim J.I., Ishigami A., et al. A. Ishigami, et al.Peptidylarginine deiminase modulates the physiological roles of enolase via citrullination: links between altered multifunction of enolase and neurodegenerative diseases. Biochem J 2012, 445:183-192.
29. Okunaga T., Urata Y., Goto S., Matsuo T., Mizota S., Tsutsumi K., et al. Calreticulin, a molecular chaperone in the endoplasmic reticulum, modulates radiosensitivity of human glioblastoma U251MG cells. Cancer Res 2006, 66:8662-8671.
30. Ortiz-Muñoz G., Houard X., Martín-Ventura J.L., Ishida B.Y., Loyau S., Rossignol P., et al. HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property. FASEB J 2009, 23:3129-3139.
31. Orr A.W., Elzie C.A., Kucik D.F., Murphy-Ullrich J.E. Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration. J Cell Sci 2003, 16:2917-2927.
32. Panaretakis T., Kepp O., Brockmeier U., Tesniere A., Bjorklund A.C., Chapman D.C., et al. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J 2009, 28:578-590.
33. Sorokina E.M., Feinstein S.I., Zhou S., Fisher A.B. Intracellular targeting of peroxiredoxin 6 to lysosomal organelles requires MAPK activity and binding to 14-3-3ε. Am J Physiol Cell Physiol 2011, 300:C1430-C1441.
34. Ko B.S. Overexpression of 14-3-3ε predicts tumour metastasis and poor survival in hepatocellular carcinoma. Histopathology 2011, 58:705-711.
35. Che X.H., Chen H., Xu Z.M., Shang C., Sun K.L., Fu W.N. 14-3-3epsilon contributes to tumour suppression in laryngeal carcinoma by affecting apoptosis and invasion. BMC Cancer 2010, 10:306.
36. Liou J.Y., Ghelani D., Yeh S., Wu K.K. Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3epsilon. Cancer Res 2007, 67:3185-3191.
37. Cao L., Cao W., Zhang W., Lin H., Yang X., Zhen H., et al. Identification of 14-3-3 protein isoforms in human astrocytoma by immunohistochemistry. Neurosci Lett 2008, 432:94-99.
38. Liu Y., Tian R.F., Li Y.M., Liu W.P., Cao L., Yang X.L., et al. The expression of seven 14-3-3 isoforms in human meningioma. Brain Res 2010, 1336:98-102.
39. Chen C.H., Chuang S.M., Yang M.F., Liao J.W., Yu S.L., Chen J.J. A Novel Function of YWHAZ/β-catenin axis in promoting epithelial-mesenchymal transition and lung cancer metastasis. Mol Cancer Res 2012, 10:1319-1331.
40. Liao C.J., Wu T.I., Huang Y.H., Chang T.C., Wang C.S., Tsai M.M., et al. Glucose-regulated protein 58 modulates cell invasiveness and serves as a prognostic marker for cervical cancer. Cancer Sci 2011, 102:2255-2263.
41. Pallero M.A., Elzie C.A., Chen J., Mosher D.F., Murphy-Ullrich J.E. Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis. FASEB J 2008, 22:3968-3979.
42. Li D., Chen P., Li X.Y., Zhang L.Y., Xiong W., Zhou M., et al. Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas. OMICS 2011, 15:673-682.
43. Chan X.H., Nama S., Gopal F., Rizk P., Ramasamy S., Sundaram G., et al. Targeting glioma stem cells by functional inhibition of a prosurvival oncomiR-138 in malignant gliomas. Cell Rep 2012, 2:591-602.
44. Sachdeva M., Zhu S., Wu F., Wu H., Walia V., Kumar S., et al. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci U S A 2009, 106:3207-3212.
45. Takaoka Y., Shimizu Y., Hasegawa H., Ouchi Y., Qiao S., Nagahara M., et al. Forced expression of miR-143 represses ERK5/c-Myc and p68/p72 signaling in concert with miR-145 in gut tumors of Apc (Min) mice. PLoS One 2012, 7:e42137.
46. Speranza M.C., Frattini V., Pisati F., Kapetis D., Porrati P., Eoli M., et al. NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma. Oncotarget 2012, 3:723-734.
47. Huang N., Lin J., Ruan J., Su N., Qing R., Liu F., et al. MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3. FEBS Lett 2012, 586:884-891.
48. Zhi F., Zhou G., Wang S., Shi Y., Peng Y., Shao N., et al. A microRNA expression signature predicts meningioma recurrence. Int J Cancer 2013, 132:128-136.
49. Rao S.A., Santosh V., Somasundaram K. Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Mod Pathol 2010, 23:1404-1417.
50. Wu X., Weng L., Li X., Guo C., Pal S.K., Jin J.M., et al. Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis. PLoS One 2012, 7:e35661.
51. Smith A.L., Iwanaga R., Drasin D.J., Micalizzi D.S., Vartuli R.L., Tan A.C., et al. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene 2012, 31:5162-5171.
52. Valera V.A., Walter B.A., Linehan W.M., Merino M.J. Regulatory effects of microRNA-92 (miR-92) on VHL gene expression and the hypoxic activation of miR-210 in clear cell renal cell carcinoma. J Cancer 2011, 2:515-526.
53. Yu X., Zhang W., Ning Q., Luo X. MicroRNA-34a inhibits human brain glioma cell growth by down-regulation of Notch1. J Huazhong Univ Sci Technolog Med Sci 2012, 32:370-374.
54. Yang S., Wang K., Qian C., Song Z., Pu P., Zhang A., et al. A predicted miR-27a-mediated network identifies a signature of glioma. Oncol 2012, 28:1249-1256.
55. Jiang J., Sun X., Wang W., Jin X., Bo X., Li Z., et al. Tumor microRNA-335 expression is associated with poor prognosis in human glioma. Med Oncol 2012, 29:3472-3477.
56. Pritchard C.C., Kroh E., Wood B., Arroyo J.D., Dougherty K.J., Miyaji M.M., et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) 2012, 5:492-497.
57. Phillips J.J. Novel therapeutic targets in the brain tumor microenvironment. Oncotarget 2012, 3:3568-3575.